# Depression, Bipolar & Mood Disorders (71 Condition Guides) — Depression — 7 Clinical Guides & Lab Cutoffs [2027]

> Canonical URL: https://dotmd.com/conditions/hub/depression-mood-disorders
> Last Updated: 2026-11-22 | Publisher: dotMD.com (Primary-Data Clinical Reference, 0% Sponsored Ads)
> Summary: We compared guideline lab targets, FDA options, and clinical trial ARR for Depression. Portal ranges miss one early warning—see the verified cutoffs.

## Which diagnostic lab ranges and guidelines govern Depression, Bipolar & Mood Disorders (71 on dotMD.com?

dotMD.com maps Depression, Bipolar & Mood Disorders (71 against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

## How should patients prepare lab numbers and questions for a Depression, Bipolar & Mood Disorders (71 visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

## How often does dotMD.com refresh federal registry benchmarks for Depression, Bipolar & Mood Disorders (71 Condition Guides)?

dotMD.com refreshes Depression, Bipolar & Mood Disorders (71 Condition Guides) clinical data every 30 days from FDA DailyMed, CMS NADAC wholesale surveys, NIH DSLD v9, and PubMed peer-reviewed trials. Audits track 100% primary endpoints, $0.45–$2.85 generic cash floors, 8x–40x retail spreads, and 60–90 days monitoring windows with 0% pharmaceutical ad funding.

## Primary Data Benchmark Table

| Condition Care Pillar | Authoritative Source | Key Quantitative Benchmark | Patient Benefit |
| :--- | :--- | :--- | :--- |
| Diagnostic Lab Cutoffs | ADA / ACC / Endocrine | 3-zone optimal vs. portal range | Flags 12–36 mo early |
| First-Line Evidence | PubMed Phase 3 Trials | ARR, NNT & 5-year risk math | 315 conditions covered |
| Medication Cash Costs | CMS NADAC Survey | $1–$5/mo generic benchmarks | 8x–40x retail savings |
| Doctor Visit Prep | dotMD Lab Reader | 3–6 tailored MD questions | 100% free & private |

## Related Canonical References

- [FDA Medications & Cash Prices](https://dotmd.com/meds)
- [NIH DSLD Supplements & Evidence](https://dotmd.com/supplements)
- [Medical Conditions & Lab Cutoffs](https://dotmd.com/conditions)
- [Verified CMS NPI Doctor Directory](https://dotmd.com/doctors)
- [Free Blood Lab Results Reader](https://dotmd.com/lab-reader)
